ArticleJournal of bone oncology2021

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer.

Arif Awan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.